Impact of inotropic therapy on mortality in cardiogenic shock following acute myocardial infarction

14 March 2025 (17:20 - 18:20)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Associate Professor Aurora Bakalli

University of Prishtina, Pristina (Kosovo Republic of)

8 More presentations in this session

Presentation thumbnail

Clinical determinants and long-term survival in heart failure with supra-normal ejection fraction. Insights from LECRA-HF registry.

Doctor K. Stepien (Krakow, PL)

Abstract Slides

Presentation thumbnail

Early predictors of in-hospital mortality in patients with acute heart failure. A general hospital experience

Doctor G. Aletras (Heraklion, GR)

Abstract Slides

Presentation thumbnail

Predictors of mortality in heart failure patients with reduced ejection fraction: neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, neutrophil- percentage-to-albumin-ratio

Doctor J. Stevic (Belgrade, RS)

Abstract Slides

Presentation thumbnail

Genetic insights into cardiomyopathy: familial and histologic features of transplant-dependent failing hearts in hcmp

Doctor K. Kim (Incheon, KR)

Abstract Slides

Presentation thumbnail

Additional benefits ofSGLT2i therapy in patients with acute decompensated heart failure and central sleep apnea.

Assistant Professor P. Kalaydzhiev (Sofia, BG)

Abstract Slides

Access the full session

Session thumbnail

Improving outcomes in acute heart failure

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March 2025 17:20 CET

You may be interested in

Congress Presentation

Etiology driven mortality in cardiogenic shock

Congress Presentation

Cardiogenic shock - can we do more?

Congress Presentation

Catecholamines in cardiogenic shock - dosis fecit venenum

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources